Reported Q: Q3 2025 Rev YoY: +13.4% EPS YoY: +36.9% Move: -0.11%
Veeva Systems Inc
VEEV
$183.65 -0.11%
Exchange: NYSE | Sector: Healthcare | Industry: Medical Healthcare Information Services
Q3 2025
Published: Dec 9, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for VEEV

Reported

Report Date

Dec 9, 2024

Quarter Q3 2025

Revenue

699.21M

YoY: +13.4%

EPS

1.13

YoY: +36.9%

Market Move

-0.11%

Previous quarter: Q2 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $699.21M up 13.4% year-over-year
  • EPS of $1.13 increased by 36.9% from previous year
  • Gross margin of 75.1%
  • Net income of 185.81M
  • "Q3 was another strong quarter of execution and innovation. We delivered financial results above our guidance with total revenue of $699 million and non-GAAP operating income of $304 million." - Peter Gassner
VEEV
Company VEEV

Executive Summary

Veeva Systems reported a solid QQ3 2025 quarter, with total revenue of $699.2 million, up 13.4% year over year, and non-GAAP operating income of $304 million. The company posted a robust gross margin of approximately 75.1% and an operating margin of about 25.9%, driving net income of $185.8 million and diluted EPS of $1.13. Management highlighted broad-based adoption across Development Cloud, including continued progress on Vault CRM and a pipeline of large strategic engagements. The quarter also featured meaningful progress in AI-enabled initiatives (GenAI) and a ramping cadence for Vault CRM migrations, with multiple top‑20 commitments and additional migrations expected in the coming quarters. Free cash flow and operating cash flow remained solid, underpinned by a strong balance sheet (net cash position of roughly $0.97 billion) and a liquidity runway that supports ongoing investments in product development and go-to-market expansion.

Looking ahead, Veeva signaled a persistent, macro-stable demand environment with continued strength in subscription growth (approximately 15% for the year) and a continued emphasis on a broad product base rather than single-product drivers. Management declined to provide formal 2026 GAAP guidance but reiterated confidence in the long-term 2030 goals, with execution quality and customer trust cited as core drivers of the business model. Key topics to watch include Vault CRM adoption among the Top 20, the economics of GenAI deployments (CRM Vault vs MLR Vault) and the monetization path for new modules like MLR Bot, ongoing data network expansion (Compass/Crossix/Data Cloud), and the integration of strategic partnerships within Development Cloud.

Overall, Veeva’s QQ3 print reinforces a durable growth profile with high operating leverage, strong cash generation, and a differentiated, cloud-first platform strategy positioned to expand penetration within the life sciences ecosystem.

Key Performance Indicators

Revenue
Increasing
699.21M
QoQ: 3.41% | YoY: 13.41%
Gross Profit
Increasing
524.82M
75.06% margin
QoQ: 3.76% | YoY: 16.93%
Operating Income
Increasing
181.35M
QoQ: 8.93% | YoY: 41.14%
Net Income
Increasing
185.81M
QoQ: 8.63% | YoY: 37.47%
EPS
Increasing
1.15
QoQ: 8.49% | YoY: 36.90%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 789.08 1.19 +16.7% View
Q1 2026 759.04 1.37 +16.7% View
Q4 2025 720.89 1.18 +14.3% View
Q3 2025 699.21 1.13 +13.4% View
Q2 2025 676.18 1.04 +14.6% View